This study is being carried out to see if ZD4054 is effective in treating prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo (sugar pill). The study will also provide further information on the safety of ZD4054.
Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study to Assess ZD4054 in Pain-Free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)
Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Eligibility & Criteria
Ages Eligible for Study: 18 Years and aboveGenders Eligible for Study: Male CriteriaInclusion Criteria:- Surgically or medically castrated – Bone metastasis – Rising PSA Exclusion Criteria:- Opiate use – Prior chemotherapy
AustraliaResearch Site, Nedlands, Australia; Recruiting Australia, QueenslandResearch Site, Wolloongabba, Queensland, Australia; Not yet recruiting Australia, South AustraliaResearch Site, Ashford, South Australia, Australia; Recruiting Australia, VictoriaResearch Site, Wodonga, Victoria, Australia; Recruiting